Inho Kim

3.6k total citations · 1 hit paper
183 papers, 1.7k citations indexed

About

Inho Kim is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Inho Kim has authored 183 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Hematology, 53 papers in Oncology and 44 papers in Genetics. Recurrent topics in Inho Kim's work include Acute Myeloid Leukemia Research (52 papers), Hematopoietic Stem Cell Transplantation (32 papers) and Multiple Myeloma Research and Treatments (31 papers). Inho Kim is often cited by papers focused on Acute Myeloid Leukemia Research (52 papers), Hematopoietic Stem Cell Transplantation (32 papers) and Multiple Myeloma Research and Treatments (31 papers). Inho Kim collaborates with scholars based in South Korea, United States and Ethiopia. Inho Kim's co-authors include Sung‐Soo Yoon, Seonyang Park, Youngil Koh, Dong‐Yeop Shin, Junshik Hong, Ja Min Byun, Javier de la Rubia, Hans Salwender, Rakesh Popat and Michèle Cavo and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Inho Kim

164 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

2020 256 citations Inho Kim et al. profile →

Peers

Inho Kim

HEMAT

ONCOL

GENET

IMMUN

Seonyang Park South Korea

Kazuteru Ohashi Japan

Leona Holmberg United States

Christof Scheid Germany

Faiz Anwer United States

Zafer Gülbaş Türkiye

Éolia Brissot France

Lori Anderson United States

David L. Becton United States

Irene Lorand‐Metze Brazil

Seonyang Park South Korea

Inho Kim

669 ×0.8

HEMAT

402 ×0.7

309 ×0.6

ONCOL

187 ×0.7

GENET

193 ×1.0

IMMUN

Citations per year, relative to Inho Kim Inho Kim (= 1×) peers Seonyang Park

Countries citing papers authored by Inho Kim

Since Specialization

Citations

This map shows the geographic impact of Inho Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inho Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inho Kim more than expected).

Fields of papers citing papers by Inho Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inho Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inho Kim. The network helps show where Inho Kim may publish in the future.

Co-authorship network of co-authors of Inho Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Inho Kim. A scholar is included among the top collaborators of Inho Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inho Kim. Inho Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Hyukmin, Moon‐Woo Seong, Ja Min Byun, et al.. (2025). Prognostic Landscape of <i>TP53</i> Mutations in Hematologic Malignancies. Cancer Research and Treatment.

Harrison, Claire, Ruben A. Mesa, Moshe Talpaz, et al.. (2024). Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial. The Lancet Haematology. 11(10). e729–e740. 11 indexed citations

Shin, Dong‐Yeop, et al.. (2024). Gene Expression and DNA Methylation Profiling Suggest Potential Biomarkers for Azacitidine Resistance in Myelodysplastic Syndrome. International Journal of Molecular Sciences. 25(9). 4723–4723. 1 indexed citations

Kim, Seokhyeon, Ja Min Byun, Junshik Hong, et al.. (2024). Phase II trial of imatinib mesylate in patients with PDGFRA/B ‐negative hypereosinophilic syndrome. British Journal of Haematology. 205(6). 2305–2314. 2 indexed citations

Park, Mi-Young, Dongho Kim, Ja Min Byun, et al.. (2024). Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea. Journal of Pain. 25(9). 104552–104552.

Youk, Jeonghwan, Ja Min Byun, Youngil Koh, et al.. (2023). Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea. European Journal Of Haematology. 112(5). 743–755. 6 indexed citations

Baek, Dong Won, Han‐Seung Park, Sang Kyun Sohn, et al.. (2023). Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study. The Korean Journal of Internal Medicine. 38(5). 734–746. 5 indexed citations

Ahn, Hyun Jin, Ja Min Byun, Inho Kim, et al.. (2022). Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. Journal of Korean Medical Science. 37(6). e48–e48. 3 indexed citations

Lee, Yeji, Inho Kim, Dong‐Yeop Shin, et al.. (2022). The immediate impact of physical function and quality of life after hematopoietic stem cell transplantation. Supportive Care in Cancer. 30(9). 7439–7446. 1 indexed citations

10.

Lee, Soon‐Tae, Ja Min Byun, Junshik Hong, et al.. (2020). High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy. Journal of Clinical Neurology. 16(4). 581–581. 3 indexed citations

11.

Byun, Ja Min, Young Nam Kwon, Youngil Koh, et al.. (2019). Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders. Scientific Reports. 9(1). 16769–16769. 4 indexed citations

12.

Hong, Junshik, Ju Hyun Lee, Ja Min Byun, et al.. (2019). Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. Blood Advances. 3(22). 3700–3708. 22 indexed citations

13.

Shin, Sue, Kyoung Un Park, Inho Kim, et al.. (2018). Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation. Annals of Laboratory Medicine. 38(6). 591–598. 7 indexed citations

14.

Han, Dohyun, Ji‐Won Kim, Youngil Koh, et al.. (2018). Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation. Blood Cells Molecules and Diseases. 74. 5–12. 7 indexed citations

15.

Park, Hyunkyung, Yoo Jin Lee, Sangjin Shin, et al.. (2018). Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population. Leukemia Research. 69. 31–38. 3 indexed citations

16.

Hong, Junshik, Woo Chan Park, Dong‐Yeop Shin, et al.. (2018). Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype. PLoS ONE. 13(12). e0209800–e0209800. 3 indexed citations

17.

Kim, Kyoung Ha, Dae‐Young Kim, Sung‐Hyun Kim, et al.. (2015). Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group. Blood. 126(23). 5166–5166. 1 indexed citations

18.

Lyu, Ha-Na, Dae‐Young Lee, Dong‐Hyun Kim, et al.. (2008). Phenolic Compounds from the Fruit Body of Phellinus linteus Increase Alkaline Phosphatase (ALP) Activity of Human Osteoblastlike Cells. Food Science and Biotechnology. 17(6). 1214–1220. 2 indexed citations

19.

Kim, Inho, et al.. (2007). Comparison of Laparoscopy-assisted Distal Gastrectomy with Open Distal Gastrectomy for Early Gastric Cancer. Journal of the Korean Surgical Society. 72(3). 189–195. 1 indexed citations

20.

Oh, Se‐Wook, et al.. (2004). Effects of Green Tea, Buckwheat and Grape Leaves Extracts on Lipid Metabolism, Antioxidative Capacity, and Antithrombotic Activity in Rats Fed High Cholesterol Diets. Korean Journal of Food Science and Technology. 36(6). 979–985. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact